Ignite Creation Date:
2025-12-24 @ 4:38 PM
Ignite Modification Date:
2026-01-26 @ 4:49 PM
Study NCT ID:
NCT03888066
Status:
COMPLETED
Last Update Posted:
2023-02-24
First Post:
2019-03-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
Sponsor:
Vifor Pharma, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hyperkalemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | treatment of hyperkalemia | View |
| None | chronic kidney disease | View |
| None | hypertension | View |
| None | hyperkalemia | View |
| None | potassium | View |
| None | spironolactone | View |
| None | heart failure | View |
| None | Renin Angiotensin-Aldosterone System Inhibitor (RAASi) | View |
| None | RAASi | View |
| None | high potassium | View |
| None | eplerenone | View |
| None | reduced ejection fraction | View |